Pulmonary arterial hypertension is a rare disease often associated with positive antinuclear
antibody and high mortality. Pulmonary hypertension, which rarely is severe, occurs …

Pulmonary hypertension is defined as a mean pulmonary artery pressure≥ 25 mm Hg and
is a recently recognized complication of chronic kidney disease and end-stage renal …

Background: We evaluated the prevalence, determinants and prognosis value of pulmonary
hypertension (PH) in non-dialysis chronic kidney disease (CKD) patients. Methods: This is a …

Introduction Pulmonary hypertension (PH) in the setting of end-stage renal disease (ESRD)
has important prognostic and therapeutic consequences. We estimated the prevalence of …

Although cardiac evaluation before kidney transplantation commonly focuses on coronary
artery disease, a comprehensive pretransplant cardiac evaluation must consider other …

Pulmonary hypertension (PH) secondary to chronic kidney disease (CKD) is common, but in
stages 1-3 CKD patients, it remains unclear. We sought to evaluate the prevalence of PH …

Background: Over the last two decades, morphological cardiac changes induced by athletic
conditioning have been of great interest. Therefore, several studies have been orchestrated …

Pulmonary hypertension (PH) is often present in patients presenting for kidney transplant
listing. While PH can complicate kidney transplant (KTx), with multidisciplinary management …

Pulmonary arterial hypertension (PAH) is a serious cardiac complication among patients
with end-stage renal disease (ESRD). We investigated pulmonary hypertension and its …

Pulmonary hypertension (PH) is a recently recognized complication of chronic kidney
disease (CKD), especially in end-stage renal disease. It has prevalence estimates of 30 …